2016
DOI: 10.1111/jcmm.13045
|View full text |Cite
|
Sign up to set email alerts
|

Vascular endothelial growth factor‐D modulates oxidant–antioxidant balance of human vascular endothelial cells

Abstract: Vascular endothelial growth factor‐D (VEGF‐D) is an angiogenic and lymphangiogenic glycoprotein that facilitates tumour growth and distant organ metastasis. Our previous studies showed that VEGF‐D stimulates the expression of proteins involved in cell–matrix interactions and promoting the migration of endothelial cells. In this study, we focused on the redox homoeostasis of endothelial cells, which is significantly altered in the process of tumour angiogenesis. Our analysis revealed up‐regulated expression of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
11
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 67 publications
(74 reference statements)
0
11
0
Order By: Relevance
“…VEGF-D, an angiogenic and lymphangiogenic glycoprotein, can facilitate tumor growth and distant organ metastasis [11] . Accumulated evidences have proved the expression of VEGF-D is usually connected with tumor metastasis and poor patient outcome.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…VEGF-D, an angiogenic and lymphangiogenic glycoprotein, can facilitate tumor growth and distant organ metastasis [11] . Accumulated evidences have proved the expression of VEGF-D is usually connected with tumor metastasis and poor patient outcome.…”
Section: Discussionmentioning
confidence: 99%
“…Vascular endothelial growth factor D (VEGF-D) is a member of VEGF family, which is the typical lymphangiopoiesis factor, which is often correlated with tumor metastasis and poor patient outcome [11] .…”
Section: Introductionmentioning
confidence: 99%
“…In our study, we established the lymphogeneous high metastasis animal model with SKOV-3 cells transfected with VEGF-D [16] , and explored the underlying mechanisms of the lymph metastasis. VEGF-D, an angiogenic and lymphangiogenic glycoprotein, can facilitate tumor growth and distant organ metastasis [11] . Accumulated evidences have proved the expression of VEGF-D is usually connected with tumor metastasis and poor patient outcome.…”
Section: Discussionmentioning
confidence: 99%
“…Vascular endothelial growth factor D (VEGF-D) is a member of VEGF family, which is the typical lymphangiopoiesis factor, and is often correlated with tumor metastasis and poor patient outcome [18] .…”
Section: Introductionmentioning
confidence: 99%